EGFR & MET
Loading...Anti-EGFR & MET Products
+ Filter
Loading...-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
-
- Target: EGFR
- Species Reactivity: Human
- Cytokine 1: IL2
- Host: Mouse
- Cytokine 1 Species: Human
- Molecule Class: IL2-IgG2a
-
- Derivation: Humanized (from rat)
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: Neut, ELISA, IF, IP, FuncS, FC, WB
-
- Derivation: Human
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: FC, IP, ELISA, Neut, FuncS, IF, WB
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: ELISA, IP, FC, FuncS, Neut, IF, IHC
-
- Derivation: Chimeric
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
- Anti-Human MET Recombinant Antibody (TAB-521CL) (TAB-521CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Antibody
- Application: WB, FuncS
-
- Derivation: Human
- Species Reactivity: Human
- Type: IgG2 - kappa
- Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
- Anti-Human Met(Onartuzumab) (TAB-190-F(E))
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Fab / Fc - G1 - kappa
- Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
-
- Derivation: Human
- Species Reactivity: Human
- Type: Human IgG
- Application: WB, Block, FuncS
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, WB
- Anti-Human EGFR Recombinant Antibody (ABT-806) (TAB-228CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Antibody
- Application: WB, IHC
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: IgG1
- Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
-
- Derivation: Human
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: ADCC enhanced antibody
- Application: ELISA, Neut
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, WB
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: ADCC enhanced antibody
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: ADCC enhanced antibody
-
- Derivation: Chimeric (Human/Mouse)
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: Neut, ELISA, IF, IP, FuncS, FC, WB
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: WB, ELISA, FC, IF, IHC, FuncS
-
- Derivation: Chimeric (human/mouse)
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: IF, WB, Inhib
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: IgG4 - kappa
- Application: FuncS, IF, Neut, ELISA, FC, IP, WB
- Human Anti-MET Recombinant Antibody; scFv Fragment (TAB-0332CL-S(P)) (TAB-0332CL-S(P))
-
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA
-
- Species Reactivity: Human
- Type: Human IgG
- Application: FC
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: FC
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: ELISA, WB, FuncS
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG
- Application: FuncS
- Human Anti-MET Recombinant Antibody (TAB-536LC) (TAB-536LC)
-
- Species Reactivity: Human
- Type: Human IgG2
- Application: Inhib
- Human Anti-MET Recombinant Antibody (TAB-537LC) (TAB-537LC)
-
- Species Reactivity: Human
- Type: Human IgG2
- Application: Inhib
- Human Anti-MET Recombinant Antibody (TAB-538LC) (TAB-538LC)
-
- Species Reactivity: Human
- Type: Human IgG2
- Application: Inhib
- Human Anti-MET Recombinant Antibody (TAB-539LC) (TAB-539LC)
-
- Species Reactivity: Human
- Type: Human IgG2
- Application: Inhib
- Human Anti-MET Recombinant Antibody (TAB-540LC) (TAB-540LC)
-
- Species Reactivity: Human
- Type: Human antibody
- Application: ELISA
-
- Species Reactivity: Human
- Type: Human IgG
- Application: Block
- Human Anti-EGFR Recombinant Antibody (TAB-0225CL) (TAB-0225CL)
-
- Derivation: Chimeric (Mouse/Human)
- Species Reactivity: Human
- Type: Chimeric (Mouse/Human) IgG1
- Application: Block, Inhib, FuncS, Apop, In vivo
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: WB
- Anti-Human MET Recombinant Antibody Fab Fragment (TAB-0530CL-F(E))
-
- Application: ELISA, FC, IF, FuncS
- Human Anti-MET Recombinant Antibody (TAB-0332CL) (TAB-0332CL)
-
- Species Reactivity: Human
- Type: Humanized Antibody
- Application: ELISA
- Anti-Human MET Recombinant Antibody (TAB-0530CL)
-
- Application: ELISA, FC, IF, FuncS
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, WB
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, WB, FuncS
- Human Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-270MZ-S(P)) (TAB-270MZ-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA
- Anti-Human MET Recombinant Antibody scFv Fragment (TAB-0530CL-S(P))
-
- Application: ELISA, FC, IF, FuncS
- Human Anti-EGFR Recombinant Antibody; Fab Fragment (TAB-0225CL-F(E)) (TAB-0225CL-F(E))
-
- Derivation: Chimeric (Mouse/Human)
- Species Reactivity: Human
- Type: Chimeric (Mouse/Human) Fab
- Application: Block, Inhib, FuncS, Apop, In vivo
- Rabbit Anti-Human EGFR (phospho Y1092) Antibody (MOB-0242MC)
-
- Species Reactivity: Rat, Human
- Application: IHC, WB
- Rabbit Anti-Human EGFR (phospho Y1068) Antibody (MOB-0243MC)
-
- Species Reactivity: Human, Mouse, Rat
- Application: IHC, WB
- Human Anti-EGFR Recombinant Antibody (TAB-270MZ) (TAB-270MZ)
-
- Species Reactivity: Human
- Type: Human antibody
- Application: ELISA
- Mouse Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-272MZ-S(P)) (TAB-272MZ-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FuncS
- Mouse Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-273MZ-S(P)) (TAB-273MZ-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FC
- Mouse Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-0564CL-S(P)) (TAB-0564CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA
- Mouse Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-271MZ-S(P)) (TAB-271MZ-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FuncS
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: WB
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: WB
-
- Derivation: Human
- Species Reactivity: Human
- Type: Human Fab
- Application: WB, Block, FuncS
- Mouse Anti-EGFR Recombinant Antibody (TAB-0564CL) (TAB-0564CL)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA
- Mouse Anti-EGFR Recombinant Antibody (TAB-0565CL) (TAB-0565CL)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA
-
- Derivation: Llama
- Species Reactivity: Human
- Type: Llama VHH
- Application: FuncS, SPR
- Mouse Anti-EGFR Recombinant Antibody; Fab Fragment (TAB-0564CL-F(E)) (TAB-0564CL-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, Neut
-
- Derivation: Llama
- Species Reactivity: Human
- Type: Llama VHH
- Application: FuncS, ELISA, IF
-
- Derivation: Llama
- Species Reactivity: Human
- Type: Llama VHH
- Application: WB, ELISA
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Block
-
- Species Reactivity: Human
- Type: Human scFv
- Application: Block
-
- Target: EGFR
- Species Reactivity: Human
- Cytokine 1: IL2
- Host: Chimeric (Mouse-Human)
- Cytokine 1 Species: Human
- Molecule Class: IgG-IL2
- 10-FnIII scaffold protein anti-Human EGFR (SFN-L003)
-
- Scaffold Name: 10-FnIII
- Target: EGFR
- Species Reactivity: Human
- Derivation: Phage display
-
- Target: EGFR
- Species Reactivity: Human
- Cytokine 1: TNFα
- Host: Mouse
- Cytokine 1 Species: Human
- Molecule Class: TNF-IgG2a
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, Neut
- Mouse Anti-MET Recombinant Antibody (TAB-534LC) (TAB-534LC)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: FC, FuncS, Inhib
- Mouse Anti-MET Recombinant Antibody (TAB-535LC) (TAB-535LC)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: FC, FuncS, Inhib
-
- Derivation: Human
- Species Reactivity: Human
- Type: Human scFv
- Application: WB, Block, FuncS
-
- Species Reactivity: Mouse
- Type: Llama VHH
- Application: ELISA, IHC, FC, FuncS
- Anti-MET immunotoxin (Fab)-PE (AGTO-G049E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FC
-
- Scaffold Name: Z-domain of protein A
- Target: EGFR
- Species Reactivity: Human
- Derivation: Phage display
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB, FuncS
-
- Species Reactivity: Human
- Type: Human scFv
- Application: FC
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA, WB, FuncS
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB, FuncS
- Anti-EGFR Antibody-Cytokine Fusion Protein, IgG-IL2 (ACFP-SH155)
-
- Target: EGFR
- Species Reactivity: Human
- Cytokine 1: IL2
- Host: Humanized from Mouse
- Cytokine 1 Species: Human
- Molecule Class: IgG1-IL2
- Anti-EGFR (ABT-806)-Mc-MMAE ADC (ABT-414) (ADC-L001)
-
- Target: EGFR
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-EGFR (J2898A)-SMCC-DM1 ADC (IMGN289) (ADC-L016)
-
- Target: EGFR
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto- 1-oxopropyl)maytansine)
- Anti-EGFR-SMCC-methotrexate ADC (ADC-059LZY)
-
- Target: EGFR
- Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
- Drug: MTX
- Anti-EGFR-doxorubicin ADC (ADC-168LZY)
-
- Target: EGFR
- Linker: polyethylene glycol linker
- Drug: doxorubicin
-
- Targets: EGFR & MET
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
- Anti-EGFR-Mal-dPEG4-NHS-DM1 ADC (ADC-107LCT)
-
- Target: EGFR
- Linker: Mal-dPEG4-NHS
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-EGFR (MAb806)-Mc-MMAF ADC (ADC-109LCT)
-
- Target: EGFR
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-EGFR (MAb806)-SMCC-DM1 ADC (ADC-110LCT)
-
- Target: EGFR variant III
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-EGFR-MC-VC-PABA-MMAE ADC (ADC-037CL)
-
- Target: EGFR
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-EGFR (clone J2898A)-SMCC-DM1 ADC (ADC-047LZY)
-
- Target: EGFR
- Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-EGFRvIII-SMCC-DM1 ADC (ADC-048LZY)
-
- Target: EGFRvIII
- Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-EGFR-MCC-Dox ADC (ADC-057LZY)
-
- Target: EGFR
- Linker: MCC (4-(N-maleimidomethyl)cyclohexane-1-carboxylate)
- Drug: doxorubicin
- Anti-EGFR-EDC/NHS-Dox ADC (ADC-058LZY)
-
- Target: EGFR
- Linker: EDC/NHS(1-ethyl-3-(3-diaminopropyl)carbodiimide/N-hydroxysuccinimide)
- Drug: doxorubicin
- Anti-EGFR (clone Bat0206)-S-3AA-MDC ADC (ADC-157CL)
-
- Target: EGFR
- Linker: S-3AA
- Drug: MDC (maytansinol)
- Anti-EGFR (clone Bat0206)-SMCC-MDC ADC (ADC-158CL)
-
- Target: EGFR
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: MDC (maytansinol)
- Anti-EGFR-MC-VC-PABA-MMAE ADC (ADC-038CL)
-
- Target: EGFR
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-EGFR-mc-MMAF ADC (ADC-039CL)
-
- Target: EGFR
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-EGFR-vc-PAB-MODO ADC (ADC-263CL)
-
- Target: epidermal growth factor receptor (EGFR)
- Linker: VC-PAB (valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MODO (monomethyldolastatin)
- Anti-EGFR-EDC/NHS-methotrexate ADC (ADC-060LZY)
-
- Target: EGFR
- Linker: EDC/NHS
- Drug: MTX
- Anti-EGFR (clone ABT-806)-mc-MMAF ADC (ADC-071LZY)
-
- Target: EGFR
- Linker: mc (maleimidocaproyl)
- Drug: MMAF (monomethyl auristatin F)
- Anti-EGFR-vc-Duostatin-3 ADC (ADC-088LZY)
-
- Target: EGFR
- Linker: VC (valine-citrulline)
- Drug: Duostatin-3
- Anti-EGFR (clone Antibody 1)-MC-MMAF ADC (ADC-059CL)
-
- Target: EGFR
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers.
The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor, thus inducing receptor dimerization and tyrosine autophosphorylation leading to cell proliferation. Mutations in this gene are associated with lung cancer. EGFR is a component of the cytokine storm which contributes to a severe form of Coronavirus Disease 2019 (COVID-19) resulting from infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).


Bladder Cancer
EGFR Tyrosine Kinase Inhibitor Resistance
Non-small Cell Lung Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Cushing Syndrome
JAK-STAT Signaling Pathway